Aditxt, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Aditxt, Inc. (ADTX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.62 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-05-20
- Aditxt, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 2.62M shares, a 44196.13% increase year-over-year.
- Aditxt, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 5.92K shares, a 80.83% decline year-over-year.
- Aditxt, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 30.91K shares.
- Aditxt, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 777.00 shares, a 87.39% decline from fiscal 2024.
- Aditxt, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 6.16K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-03-31 | 2.62M shares 10-Q · filed 2026-05-20 | |||
| 2025-12-31 | 777.00 shares 10-K · filed 2026-03-31 | |||
| 2025-09-30 | 5.46K shares 10-Q · filed 2025-11-18 | |||
| 2025-06-30 | 605.89K shares 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | 5.92K shares 10-Q · filed 2025-05-15 | |||
| 2024-12-31 | 6.16K shares 10-K · filed 2025-03-31 | |||
| 2024-09-30 | 1.53M shares 10-Q · filed 2024-11-18 | |||
| 2024-06-30 | 20.57M shares 10-Q · filed 2024-08-19 | |||
| 2024-03-31 | 30.91K shares 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |